Lowers the risk of myocardial infarction, myocardial revascularization procedures, and…. ANDA 76341, held by Apotex. Pravastatin Sodium.
As of Nov 16, 2026, ANDA 76341 (Pravastatin Sodium), held by Apotex, was first approved by FDA on Oct 23, 2006, with 8 approved supplements and 0 published complete response letters.
Pravastatin sodium tablets are indicated: To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD). To reduce the risk of coronary death, myocardial infarction, myocardial revascularization procedures, stroke or transient ischemic attack, and slow the progression of coronary atherosclerosis in adults with clinically evident CHD. As an adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 23, 2006 | Original application | Approved | None posted |
| Pravastatin Sodium10MG · tablet;oral | Pravastatin Sodium | Rx |
| Pravastatin Sodium20MG · tablet;oral | Pravastatin Sodium | Rx |
| Pravastatin Sodium40MG · tablet;oral | Pravastatin Sodium | Rx |
| Pravastatin Sodium80MG · tablet;oral | Pravastatin Sodium | Rx |
| Feb 18, 2025 | Supplement 31Labeling · Standard review | Approved | None posted |
| Apr 26, 2023 | Supplement 26Labeling · Standard review | Approved | None posted |
| Mar 5, 2021 | Supplement 25Labeling · Standard review | Approved | None posted |
| Jul 7, 2017 | Supplement 19Labeling · Standard review | Approved | None posted |
| Jul 26, 2013 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jul 12, 2012 | Supplement 13Labeling | Approved | None posted |
| Dec 28, 2007 | Supplement 2Labeling | Approved | None posted |
| Dec 28, 2007 | Supplement 1Manufacturing | Approved | None posted |
| Oct 23, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters